Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE51005 |
| Title | Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy |
| Description | Early chemotherapy for advanced/metastatic non-castration resistant prostate cancer (PCa) may improve overall patient survival. We studied the safety, tolerability and early efficacy of up-front docetaxel chemotherapy and androgen deprivation therapy (ADT) versus ADT alone for patients with newly-diagnosed advanced/metastatic PCa. As proof of concept, we undertook in vivo gene expression profiling by next generation RNA sequencing (RNA-Seq). |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51005 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
